Contributor

Kristin Houser

Staff Writer

Contact

kristin.houser@freethink.com

Kristin Houser is a staff writer at Freethink, where she covers science and tech. Her written work has appeared in Business Insider, NBC News, and the World Economic Forum’s Agenda, among other publications, and Stephen Colbert once talked about a piece on The Late Show, to her delight.

Prior to joining Freethink, Kristin was a staff writer for Futurism and wrote several animated and live action web series.

Coronavirus

Converting shipping containers into ICUs for coronavirus patients

The CURA project aims to address the shortage of room in ICUs for coronavirus patients by creating new units out of shipping containers.

Kristin Houser

Coronavirus

Antiviral pill shows promise as treatment for coronavirus

The oral antiviral drug EIDD-2801 has emerged as a promising treatment for coronavirus, performing well in the lab and in mouse studies.

Kristin Houser

Coronavirus

New coronavirus test could check one million people daily

BillionToOne has announced the creation of a coronavirus test it says would allow the U.S. to check more than one million people for COVID-19 daily.

Kristin Houser

Coronavirus

Scientists analyze sewage to track coronavirus infections

Scientists are attempting to track coronavirus infections by analyzing sewage for signs of the virus’ genetic material.

Kristin Houser

Coronavirus

Plasma from coronavirus survivors helps sick patients recover

Two studies in China found that plasma from coronavirus survivors helps patients with severe cases of COVID-19 recover within days of treatment.

Kristin Houser

Coronavirus

Contact-tracing apps could help end coronavirus lockdown

A new University of Oxford study found that contact-tracing apps could help bring the coronavirus pandemic to an end without violating citizens' rights.

Kristin Houser

Coronavirus

Bill Gates is spending billions to produce 7 coronavirus vaccines

The Gates Foundation is building factories to manufacture seven promising coronavirus vaccines to prepare for mass production if any prove effective.

Kristin Houser

Coronavirus

Group coronavirus testing helps make most of limited kits

Researchers across the globe are testing the efficacy of group coronavirus testing — using one kit for multiple patients — with promising results.

Kristin Houser

Coronavirus

New tool seeks to protect those reusing coronavirus masks

A group of researchers launched a website that teaches healthcare workers everything they need to know about reusing coronavirus masks as safely as possible.

Kristin Houser

Coronavirus

Big tobacco announces "breakthrough" in plant-based coronavirus vaccine

A plant-based coronavirus vaccine developed by a subsidiary of British American Tobacco is now undergoing pre-clinical testing.

Kristin Houser